$39.49
-0.41-1.03%
al cierre: Sep 1, 5:00 PM EST
$39.49
-0.41-1.03%
Premercado: 4:31 AM EST
Immunovant Inc
IMVTNASDAQ
Immunovant Earnings & Forecasts
Immunovant (IMVT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Immunovant Guidance
Recent Earnings Results
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.52 | $-0.62 | $-0.71 | $-0.72 |
| Actual | $-0.75 | $-0.73 | $-0.61 | $-0.73 |
| Surprise | -44.2% | -17.7% | +14.1% | -1.39% |
| Revenue | ||||
| Estimate | — | — | $2.4M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.72 | $-0.68 | $-0.73 | $-0.70 |
| Revenue | ||||
| Consensus | — | — | — | — |